Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.50
Bid: 16.00
Ask: 17.00
Change: -0.25 (-1.49%)
Spread: 1.00 (6.25%)
Open: 16.75
High: 16.75
Low: 16.50
Prev. Close: 16.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix products launch into retail in Australia, New Zealand

Mon, 12th Oct 2020 14:00

(Sharecast News) - Life sciences company OptiBiotix Health announced the launch of meal replacement shakes and bars containing its 'OptiBiome' proprietary weight management technology under the 'Optislim' brand with the Woolworths and Chemist Warehouse retailers, and online, in Australia and New Zealand.

The AIM-traded firm said the simultaneous launches built on a licence agreement entered into in March, which granted OptiPharm exclusive use of the OptiBiome trademark in Australia, parts of Asia, New Zealand, the Middle East, the Gulf States and North America, with an extension of terms in August to include Europe.

It described OptiPharm as a privately-owned Australian company, which has been operating for 24 years.

Its flagship brand , 'Optislim', is the top Australian weight management brand incorporating shakes, soups and bars available as total and partial meal replacements.

"We are very pleased to announce the commercial launch of these weight management products containing OptiBiome under OptiPharm's Optislim brand," said Dr Fred Narbel, managing director of OptiBiotix's prebiotics division.

"OptiBiotix's partnership with Australia's No. 1 weight management brand combined with the retailers' distribution network allows the company to access a wide base of customers in Australia and New Zealand and provide them with a scientifically proven and award-winning ingredient to help them achieve their weight loss.

"This first commercial step with OptiPharm highlights the strength of the relationship between the two companies and we look forward to future commercial launches beyond Australia and New Zealand."

At 1356 BST, shares in OptiBiotix Health were down 0.66% at 59.11p.
More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.